Showing results (151-160 of 318) with videos related to
Sort By:
Pageof 32
Science (New York, N.Y.)|August 21, 1992
The mouse pink-eyed dilution gene: association with human Prader-Willi and Angelman syndromesJ M Gardner, Y Nakatsu, Y Gondo, et al.BMC Medical Genomics|January 16, 2014
Validation of PhenX measures in the personalized medicine research project for use in gene/environment studiesCatherine A McCarty, Richard Berg, Carla M Rottscheit, et al.International Journal of Epidemiology|January 1, 1989
Rapid epidemiologic assessment of cataract blindness. The Aravind Rapid Epidemiologic Assessment StaffG Venkataswamy, J M Lepkowski, T Ravilla, et al.Rwanda Journal of Medicine and Health Sciences|June 26, 2025
Barriers to Community Pharmacists' Prescribing Role in Limpopo Province, South Africa: A Qualitative StudyNoko Brilliant Moloto, Tiisetso Aubrey Chuene, Kgaugelo Daphney Makgopa, et al.Southern Medical Journal|March 1, 1996
Hemolytic-uremic syndrome without evidence of microangiopathic hemolytic anemia on peripheral blood smearS E Brilliant, P A Lester, A K Ohno, et al.The Journal of Investigative Dermatology|May 14, 1998
Identification of a novel transcript produced by the gene responsible for the Hermansky-Pudlak syndrome in Puerto RicoS C Wildenberg, J P Fryer, J M Gardner, et al.Ophthalmology Science|October 17, 2022
Assessing Foveal Structure in Individuals with TYR R402Q and S192Y Hypomorphic AllelesGelique D Ayala, Rachel E Linderman, Robert K Valenzuela, et al.Frontiers in Medicine|November 29, 2023
Estimating the efficacy of pharmacogenomics over a lifetimeZhan Ye, John Mayer, Emili J Leary, et al.Experimental and Molecular Pathology|July 27, 2010
Accumulation of neoplastic traits prior to spontaneous in vitro transformation of rat cholangiocytes determines susceptibility to activated ErbB-2/NeuRebecca A Rozich, David R Mills, Kate E Brilliant, et al.Pigment Cell Research|December 1, 1994
The mouse pink-eyed dilution gene: association with hypopigmentation in Prader-Willi and Angelman syndromes and with human OCA2M H Brilliant, R King, U Francke, et al.Pageof 32